Analysis of the plasma proteome using iTRAQ and TMT-based Isobaric labeling.

Over the past decade, chemical labeling with isobaric tandem mass tags, such as isobaric tags for relative and absolute quantification reagents (iTRAQ) and tandem mass tag (TMT) reagents, has been employed in a wide range of different clinically orientated serum and plasma proteomics studies. In this review the scope of these works is presented with attention to the areas of research, methods employed and performance limitations. These applications have covered a wide range of diseases, disorders and infections, and have implemented a variety of different preparative and mass spectrometric approaches. In contrast to earlier works, which struggled to quantify more than a few hundred proteins, increasingly these studies have provided deeper insight into the plasma proteome extending the numbers of quantified proteins to over a thousand.

[1]  Paul Bowness,et al.  Discovery of Candidate Serum Proteomic and Metabolomic Biomarkers in Ankylosing Spondylitis* , 2011, Molecular & Cellular Proteomics.

[2]  Peter Rossing,et al.  Quantitative iTRAQ-Based Proteomic Identification of Candidate Biomarkers for Diabetic Nephropathy in Plasma of Type 1 Diabetic Patients , 2010, Clinical Proteomics.

[3]  H. Gabra,et al.  Identification of proteomic and metabolic signatures associated with chemoresistance of human epithelial ovarian cancer. , 2016, International journal of oncology.

[4]  H. Ressom,et al.  iTRAQ-based quantitative protein expression profiling and MRM verification of markers in type 2 diabetes. , 2012, Journal of proteome research.

[5]  Karl Mechtler,et al.  Peptide Labeling with Isobaric Tags Yields Higher Identification Rates Using iTRAQ 4-Plex Compared to TMT 6-Plex and iTRAQ 8-Plex on LTQ Orbitrap , 2010, Analytical chemistry.

[6]  M. Kasuga,et al.  Differential proteome analysis of serum proteins associated with the development of type 2 diabetes mellitus in the KK-A(y) mouse model using the iTRAQ technique. , 2013, Journal of proteomics.

[7]  Hai‐Tao Hou,et al.  Plasma Proteomic Study in Pulmonary Arterial Hypertension Associated with Congenital Heart Diseases , 2016, Scientific Reports.

[8]  J. Ping,et al.  Comparative serum proteomic analysis of adenomyosis using the isobaric tags for relative and absolute quantitation technique. , 2013, Fertility and sterility.

[9]  M. I. Mora,et al.  Multicentric study of the effect of pre-analytical variables in the quality of plasma samples stored in biobanks using different complementary proteomic methods. , 2017, Journal of proteomics.

[10]  Dana Pascovici,et al.  Quantitative Age-specific Variability of Plasma Proteins in Healthy Neonates, Children and Adults* , 2017, Molecular & Cellular Proteomics.

[11]  G. Clifton,et al.  Identification of serum biomarkers in brain-injured adults: potential for predicting elevated intracranial pressure. , 2008, Journal of neurotrauma.

[12]  J. Rajapakse,et al.  Serum Proteome and Cytokine Analysis in a Longitudinal Cohort of Adults with Primary Dengue Infection Reveals Predictive Markers of DHF , 2012, PLoS neglected tropical diseases.

[13]  D. Tuveson,et al.  Decreased Serum Thrombospondin-1 Levels in Pancreatic Cancer Patients Up to 24 Months Prior to Clinical Diagnosis: Association with Diabetes Mellitus , 2015, Clinical Cancer Research.

[14]  Ingo Ruczinski,et al.  Plasma Proteome Biomarkers of Inflammation in School Aged Children in Nepal , 2015, PloS one.

[15]  P. Xie,et al.  Comparative proteomic analysis of plasma from major depressive patients: identification of proteins associated with lipid metabolism and immunoregulation. , 2012, The international journal of neuropsychopharmacology.

[16]  P. Wright,et al.  Quantitation with chemical tagging reagents in biomarker studies , 2015, Proteomics. Clinical applications.

[17]  Kai A. Reidegeld,et al.  Protein labeling by iTRAQ: A new tool for quantitative mass spectrometry in proteome research , 2007, Proteomics.

[18]  H. Fox,et al.  Comparison of 4-plex to 8-plex iTRAQ Quantitative Measurements of Proteins in Human Plasma Samples , 2012, Journal of proteome research.

[19]  Jiye Ai,et al.  Discovery of potential serum protein biomarkers for lymph node metastasis in oral cancer , 2016, Head & neck.

[20]  M. Loh,et al.  Upregulation of plasma C9 protein in gastric cancer patients , 2010, Proteomics.

[21]  Hasmik Keshishian,et al.  Quantitative, multiplexed workflow for deep analysis of human blood plasma and biomarker discovery by mass spectrometry , 2017, Nature Protocols.

[22]  C. Corless,et al.  Novel Biomarker Candidates to Predict Hepatic Fibrosis in Hepatitis C Identified by Serum Proteomics , 2011, Digestive Diseases and Sciences.

[23]  Michael J. Walker,et al.  Discovery and Validation of Predictive Biomarkers of Survival for Non-small Cell Lung Cancer Patients Undergoing Radical Radiotherapy: Two Proteins With Predictive Value , 2015, EBioMedicine.

[24]  P. Jenö,et al.  Quantitative Proteomic (iTRAQ) Analysis of 1st Trimester Maternal Plasma Samples in Pregnancies at Risk for Preeclampsia , 2012, Journal of biomedicine & biotechnology.

[25]  Matthias Mann,et al.  Proteomics reveals the effects of sustained weight loss on the human plasma proteome , 2016, Molecular systems biology.

[26]  Ken-ichi Matsumoto,et al.  Plasma proteomic changes during hypothermic and normothermic cardiopulmonary bypass in aortic surgeries , 2014, International journal of molecular medicine.

[27]  Kelly A. Jones,et al.  Assessment of two immunodepletion methods: off-target effects and variations in immunodepletion efficiency may confound plasma proteomics. , 2012, Journal of proteome research.

[28]  A. Roses,et al.  Identification of plasma biomarkers of TBI outcome using proteomic approaches in an APOE mouse model. , 2012, Journal of neurotrauma.

[29]  J. Stulík,et al.  Plasma concentration of fibronectin is decreased in patients with hypertrophic cardiomyopathy. , 2016, Clinica chimica acta; international journal of clinical chemistry.

[30]  P. Xie,et al.  Plasma-based proteomics reveals lipid metabolic and immunoregulatory dysregulation in post-stroke depression , 2014, European Psychiatry.

[31]  J. Ping,et al.  Serum differential proteomic analysis of endometriosis and adenomyosis by iTRAQ technique. , 2014, European journal of obstetrics, gynecology, and reproductive biology.

[32]  T. Zhu,et al.  Analysis of transcriptional factors and regulation networks in patients with acute renal allograft rejection. , 2011, Journal of proteome research.

[33]  G. Ginsburg,et al.  Discovery of biomarker candidates for coronary artery disease from an APOE‐knock out mouse model using iTRAQ‐based multiplex quantitative proteomics , 2011, Proteomics.

[34]  J. Timms,et al.  Quantitative profiling of serum samples using TMT protein labelling, fractionation and LC-MS/MS. , 2011, Methods.

[35]  Dirk Valkenborg,et al.  This item is the archived peer-reviewed author-version of: CONSTANd : a normalization method for isobaric labeled spectra by constrained optimization , 2022 .

[36]  Ping Zhang,et al.  A proteomic approach for plasma biomarker discovery with 8-plex iTRAQ labeling and SCX-LC-MS/MS , 2010, Molecular and Cellular Biochemistry.

[37]  Xiaomin Song,et al.  iTRAQ experimental design for plasma biomarker discovery. , 2008, Journal of proteome research.

[38]  Akhilesh Pandey,et al.  Identification of differentially expressed serum proteins in gastric adenocarcinoma. , 2015, Journal of proteomics.

[39]  Y. Lau,et al.  Identification of Protein Markers in Patients Infected with Plasmodium knowlesi, Plasmodium falciparum and Plasmodium vivax , 2014, International journal of molecular sciences.

[40]  Andrew J. Percy,et al.  Multiple Reaction Monitoring Enables Precise Quantification of 97 Proteins in Dried Blood Spots* , 2015, Molecular & Cellular Proteomics.

[41]  L. Richeldi,et al.  A Quantitative Proteomic Approach to Identify Significantly Altered Protein Networks in the Serum of Patients with Lymphangioleiomyomatosis (LAM) , 2014, PloS one.

[42]  Kristin L Cheek,et al.  Depletion of abundant plasma proteins and limitations of plasma proteomics. , 2010, Journal of proteome research.

[43]  T. Naka,et al.  Screening for novel serum biomarker for monitoring disease activity in rheumatoid arthritis using iTRAQ technology-based quantitative proteomic approach. , 2014, Methods in molecular biology.

[44]  Josselin Noirel,et al.  Minimising iTRAQ ratio compression through understanding LC‐MS elution dependence and high‐resolution HILIC fractionation , 2011, Proteomics.

[45]  J. Rao,et al.  Quantitative Proteomics Analysis by Isobaric Tags for Relative and Absolute Quantitation Identified Lumican as a Potential Marker for Acute Aortic Dissection , 2011, Journal of biomedicine & biotechnology.

[46]  M. Larsen,et al.  Plasma proteome profiling of atherosclerotic disease manifestations reveals elevated levels of the cytoskeletal protein vinculin. , 2014, Journal of proteomics.

[47]  S. Carr,et al.  A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease , 2011, Nature Biotechnology.

[48]  R. Cole,et al.  The Plasma Proteome Identifies Expected and Novel Proteins Correlated with Micronutrient Status in Undernourished Nepalese Children 1 – 3 , 2013 .

[49]  Unraveling biomarkers of abdominal aortic aneurisms by iTRAQ analysis of depleted plasma. , 2013, Methods in molecular biology.

[50]  J. Lehtiö,et al.  A novel prefractionation method combining protein and peptide isoelectric focusing in immobilized pH gradient strips. , 2013, Journal of proteome research.

[51]  Jennifer K. Miller,et al.  Quantitative Proteomics for Cardiac Biomarker Discovery Using Isoproterenol-Treated Nonhuman Primates , 2014, Journal of proteome research.

[52]  Michelle A. Anderson,et al.  Large-scale identification of core-fucosylated glycopeptide sites in pancreatic cancer serum using mass spectrometry. , 2015, Journal of proteome research.

[53]  O. Krokhin,et al.  Assessment of the reproducibility of random hexapeptide peptide library-based protein normalization. , 2010, Journal of proteome research.

[54]  James R. Anderson,et al.  Plasma proteomic analysis of simian immunodeficiency virus infection of rhesus macaques. , 2010, Journal of proteome research.

[55]  Xi Liu,et al.  Alpha-2-macroglobulin and heparin cofactor II and the vulnerability of carotid atherosclerotic plaques: An iTRAQ-based analysis. , 2017, Biochemical and biophysical research communications.

[56]  R. Philip,et al.  Investigation of plasma biomarkers in HIV-1/HCV mono- and coinfected individuals by multiplex iTRAQ quantitative proteomics. , 2011, Omics : a journal of integrative biology.

[57]  Mark McEvoy,et al.  Plasma protein profiling of mild cognitive impairment and Alzheimer's disease across two independent cohorts. , 2014, Journal of Alzheimer's disease : JAD.

[58]  Yin-kun Liu,et al.  High-throughput screening of tumor metastatic-related differential glycoprotein in hepatocellular carcinoma by iTRAQ combines lectin-related techniques , 2013, Medical Oncology.

[59]  Shen Hu,et al.  Quantitative Proteomic Analysis of Serum Proteins from Oral Cancer Patients: Comparison of Two Analytical Methods , 2014, International journal of molecular sciences.

[60]  M. Stobiecki,et al.  Optimization of Plasma Sample Pretreatment for Quantitative Analysis Using iTRAQ Labeling and LC-MALDI-TOF/TOF , 2014, PloS one.

[61]  Ravi Sirdeshmukh,et al.  Proteins with Altered Levels in Plasma from Glioblastoma Patients as Revealed by iTRAQ-Based Quantitative Proteomic Analysis , 2012, PloS one.

[62]  M. Kussmann,et al.  Comprehensive and Scalable Highly Automated MS-Based Proteomic Workflow for Clinical Biomarker Discovery in Human Plasma. , 2014, Journal of proteome research.

[63]  Eithne Costello,et al.  A technically detailed and pragmatic protocol for quantitative serum proteomics using iTRAQ. , 2009, Journal of proteomics.

[64]  Ken-ichi Matsumoto,et al.  Monitoring of Serial Presurgical and Postsurgical Changes in the Serum Proteome in a Series of Patients with Calcific Aortic Stenosis , 2015, Disease markers.

[65]  D. Angus,et al.  Proteomics reveals age-related differences in the host immune response to sepsis. , 2014, Journal of proteome research.

[66]  Caroline Dive,et al.  Statistical Considerations of Optimal Study Design for Human Plasma Proteomics and Biomarker Discovery , 2012, Journal of proteome research.

[67]  Bruno Domon,et al.  Large-Scale Targeted Proteomics Using Internal Standard Triggered-Parallel Reaction Monitoring (IS-PRM)* , 2015, Molecular & Cellular Proteomics.

[68]  S. Sze,et al.  Discovery of Prognostic Biomarker Candidates of Lacunar Infarction by Quantitative Proteomics of Microvesicles Enriched Plasma , 2014, PloS one.

[69]  N. Gregersen,et al.  Plasma and urine proteomic profiles in childhood idiopathic nephrotic syndrome , 2012, Proteomics. Clinical applications.

[70]  Jennifer M. Campbell,et al.  Semi-targeted plasma proteomics discovery workflow utilizing two-stage protein depletion and off-line LC-MALDI MS/MS. , 2011, Journal of proteome research.

[71]  Olli Simell,et al.  Serum Proteomes Distinguish Children Developing Type 1 Diabetes in a Cohort With HLA-Conferred Susceptibility , 2015, Diabetes.

[72]  M. Dhaenens,et al.  Comparative proteome analysis of porcine follicular fluid and serum reveals that excessive α2‐macroglobulin in serum hampers successful expansion of cumulus‐oocyte complexes , 2009, Proteomics.

[73]  Andrew H. Thompson,et al.  Tandem mass tags: a novel quantification strategy for comparative analysis of complex protein mixtures by MS/MS. , 2003, Analytical chemistry.

[74]  Leo Uchida,et al.  A Proteomic Approach Identifies Candidate Early Biomarkers to Predict Severe Dengue in Children , 2016, PLoS neglected tropical diseases.

[75]  Li Li,et al.  Proteomic analysis of serum of women with elevated Ca-125 to differentiate malignant from benign ovarian tumors. , 2012, Asian Pacific journal of cancer prevention : APJCP.

[76]  Hoguen Kim,et al.  Simple method for quantitative analysis of N-linked glycoproteins in hepatocellular carcinoma specimens. , 2010, Journal of proteome research.

[77]  T. Libermann,et al.  Identification of a novel potential biomarker in a model of hemorrhagic shock and valproic acid treatment. , 2010, The Journal of surgical research.

[78]  T. Lawrence,et al.  Quantitative Proteomic Analysis of Serum Exosomes from Patients with Locally Advanced Pancreatic Cancer Undergoing Chemoradiotherapy. , 2017, Journal of proteome research.

[79]  B. McManus,et al.  Plasma protein biosignatures for detection of cardiac allograft vasculopathy. , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[80]  Joanna-Marie Howes Proteomic profiling of plasma microparticles following deep-vein thrombosis , 2010, Expert review of proteomics.

[81]  Ingo Ruczinski,et al.  Statistical inference from multiple iTRAQ experiments without using common reference standards. , 2013, Journal of proteome research.

[82]  Yurong Gu,et al.  Serum proteomics analysis and comparisons using iTRAQ in the progression of hepatitis B , 2013, Experimental and therapeutic medicine.

[83]  A. Rosenberg,et al.  Low abundance protein enrichment for discovery of candidate plasma protein biomarkers for early detection of breast cancer. , 2011, Journal of proteomics.

[84]  D. Dai,et al.  Serum proteomics in multiple sclerosis disease progression. , 2015, Journal of proteomics.

[85]  O. Krokhin,et al.  The effects of infliximab therapy on the serum proteome of rheumatoid arthritis patients , 2009, Arthritis research & therapy.

[86]  J. Yates,et al.  Isobaric Labeling-Based Relative Quantification in Shotgun Proteomics , 2014, Journal of proteome research.

[87]  S. Nie,et al.  Isobaric protein-level labeling strategy for serum glycoprotein quantification analysis by liquid chromatography-tandem mass spectrometry. , 2013, Analytical chemistry.

[88]  Yiping Huang,et al.  Discovery of serum biomarkers implicated in the onset and progression of serous ovarian cancer in a rat model using iTRAQ technique. , 2012, European journal of obstetrics, gynecology, and reproductive biology.

[89]  Sanjeeva Srivastava,et al.  Differential expression of serum/plasma proteins in various infectious diseases: Specific or nonspecific signatures , 2013, Proteomics. Clinical applications.

[90]  M. Rewers,et al.  Temporal profiles of plasma proteome during childhood development. , 2017, Journal of proteomics.

[91]  M. Westphall,et al.  Gas-phase purification enables accurate, large-scale, multiplexed proteome quantification with isobaric tagging , 2011, Nature Methods.

[92]  S. Laboissiere,et al.  Serum proteomic approach for the identification of serum biomarkers contributed by oral squamous cell carcinoma and host tissue microenvironment. , 2009, Journal of proteome research.

[93]  Frank Kjeldsen,et al.  Undesirable charge-enhancement of isobaric tagged phosphopeptides leads to reduced identification efficiency. , 2010, Journal of proteome research.

[94]  Martin Wühr,et al.  A Strategy to Combine Sample Multiplexing with Targeted Proteomics Assays for High-Throughput Protein Signature Characterization. , 2017, Molecular cell.

[95]  H. Saya,et al.  Proteome profiling reveals gender differences in the composition of human serum , 2010, Proteomics.

[96]  Pengyuan Yang,et al.  Identification of transaldolase as a novel serum biomarker for hepatocellular carcinoma metastasis using xenografted mouse model and clinic samples. , 2011, Cancer letters.

[97]  Mingshi Yang,et al.  Identification of Potential Biomarkers by Serum Proteomics Analysis in Rats with Sepsis , 2014, Shock.

[98]  Richard B. Thompson,et al.  Gender‐specific plasma proteomic biomarkers in patients with Anderson–Fabry disease , 2015, European journal of heart failure.

[99]  Pengyuan Yang,et al.  Quantitative proteomic analysis of serum proteins in patients with Parkinson's disease using an isobaric tag for relative and absolute quantification labeling, two-dimensional liquid chromatography, and tandem mass spectrometry. , 2012, The Analyst.

[100]  L. Puybasset,et al.  Measuring Serum Amyloid A for Infection Prediction in Aneurysmal Subarachnoid Hemorrhage. , 2015, Journal of proteome research.

[101]  R. Cole,et al.  Maternal serum proteome changes between the first and third trimester of pregnancy in rural southern Nepal. , 2012, Placenta.

[102]  D. Accili,et al.  Altered Plasma Profile of Antioxidant Proteins as an Early Correlate of Pancreatic β Cell Dysfunction* , 2016, The Journal of Biological Chemistry.

[103]  Jicheng Li,et al.  Serum Protein KNG1, APOC3, and PON1 as Potential Biomarkers for Yin-Deficiency-Heat Syndrome , 2016, Evidence-based complementary and alternative medicine : eCAM.

[104]  H. Fan,et al.  iTRAQ-based Quantitative Proteomics Study in Patients with Refractory Mycoplasma pneumoniae Pneumonia. , 2017, Japanese journal of infectious diseases.

[105]  Loïc Dayon,et al.  Proteomic Biomarker Discovery in 1000 Human Plasma Samples with Mass Spectrometry. , 2016, Journal of proteome research.

[106]  F. Pociot,et al.  Plasma proteome analysis of patients with type 1 diabetes with diabetic nephropathy , 2010, Proteome Science.

[107]  D. Goodlett,et al.  The progress and potential of proteomic biomarkers for type 1 diabetes in children , 2017, Expert review of proteomics.

[108]  Henry Brodaty,et al.  Plasma protein profiling of Mild Cognitive Impairment and Alzheimer’s disease using iTRAQ quantitative proteomics , 2014, Proteome Science.

[109]  Christoph H Borchers,et al.  Multiplexed MRM‐based quantitation of candidate cancer biomarker proteins in undepleted and non‐enriched human plasma , 2013, Proteomics.

[110]  S. Tannenbaum,et al.  Comparative time-dependent analysis of potential inflammation biomarkers in lymphoma-bearing SJL mice. , 2007, Journal of proteome research.

[111]  R. Lewensohn,et al.  Use of narrow‐range peptide IEF to improve detection of lung adenocarcinoma markers in plasma and pleural effusion , 2009, Proteomics.

[112]  Ming Yao,et al.  SWATH™- and iTRAQ-based quantitative proteomic analyses reveal an overexpression and biological relevance of CD109 in advanced NSCLC. , 2014, Journal of proteomics.

[113]  N. Anderson,et al.  The Human Plasma Proteome , 2002, Molecular & Cellular Proteomics.

[114]  A. V. D. Van Der Zee,et al.  A panel of regulated proteins in serum from patients with cervical intraepithelial neoplasia and cervical cancer. , 2014, Journal of proteome research.

[115]  H. Upur,et al.  Identification of plasma protein markers common to patients with malignant tumour and Abnormal Savda in Uighur medicine: a prospective clinical study , 2015, BMC Complementary and Alternative Medicine.

[116]  F. Guillonneau,et al.  Serum profile in preeclampsia and intra-uterine growth restriction revealed by iTRAQ technology. , 2010, Journal of proteomics.

[117]  G. Chrousos,et al.  Whole serum 3D LC-nESI-FTMS quantitative proteomics reveals sexual dimorphism in the milieu intérieur of overweight and obese adults. , 2014, Journal of proteome research.

[118]  Wei Ma,et al.  Comprehensive maternal serum proteomics identifies the cytoskeletal proteins as non-invasive biomarkers in prenatal diagnosis of congenital heart defects , 2016, Scientific Reports.

[119]  R. Christopherson,et al.  Protein profiles distinguish stable and progressive chronic lymphocytic leukemia , 2016, Leukemia & lymphoma.

[120]  Lloyd M. Smith,et al.  Proteoform: a single term describing protein complexity , 2013, Nature Methods.

[121]  Dhanashree S. Kelkar,et al.  Proteomic Signature of Endothelial Dysfunction Identified in the Serum of Acute Ischemic Stroke Patients by the iTRAQ-Based LC-MS Approach. , 2015, Journal of proteome research.

[122]  Han-Zhong Li,et al.  iTRAQ-Based Quantitative Proteomic Analysis Identified HSC71 as a Novel Serum Biomarker for Renal Cell Carcinoma , 2015, BioMed research international.

[123]  K. Shedden,et al.  Mass-Selected Site-Specific Core-Fucosylation of Serum Proteins in Hepatocellular Carcinoma. , 2015, Journal of proteome research.

[124]  C. Lynch,et al.  Apolipoprotein A‐IV, a Putative Satiety/Antiatherogenic Factor, Rises After Gastric Bypass , 2009, Obesity.

[125]  Janne Lehtiö,et al.  Mass spectrometry-based plasma proteomics: state of the art and future outlook , 2014, Expert review of proteomics.

[126]  Duan Ma,et al.  Quantitative Proteomic Analysis of Serum from Pregnant Women Carrying a Fetus with Conotruncal Heart Defect Using Isobaric Tags for Relative and Absolute Quantitation (iTRAQ) Labeling , 2014, PloS one.

[127]  S. Michelland,et al.  Peptides OFFGEL electrophoresis: a suitable pre-analytical step for complex eukaryotic samples fractionation compatible with quantitative iTRAQ labeling , 2008, Proteome Science.

[128]  J. Russo,et al.  Alterations in the Rat Serum Proteome Induced by Prepubertal Exposure to Bisphenol A and Genistein , 2014, Journal of proteome research.

[129]  Daniel G. Jamieson,et al.  Detection of candidate biomarkers of prostate cancer progression in serum: a depletion-free 3D LC/MS quantitative proteomics pilot study , 2016, British Journal of Cancer.

[130]  Minoru Fujimoto,et al.  iTRAQ-based proteomic identification of leucine-rich α-2 glycoprotein as a novel inflammatory biomarker in autoimmune diseases , 2009, Annals of the rheumatic diseases.

[131]  A. J. Markvoort,et al.  Proteomic Analysis in Type 2 Diabetes Patients before and after a Very Low Calorie Diet Reveals Potential Disease State and Intervention Specific Biomarkers , 2014, PloS one.

[132]  Ping Xu,et al.  A Pro-Atherogenic HDL Profile in Coronary Heart Disease Patients: An iTRAQ Labelling-Based Proteomic Approach , 2014, PloS one.

[133]  Edward L. Huttlin,et al.  Increasing the multiplexing capacity of TMTs using reporter ion isotopologues with isobaric masses. , 2012, Analytical chemistry.

[134]  Y. Takasaki,et al.  Serum Proteome Analysis in Patients with Rheumatoid Arthritis Receiving Therapy with Tocilizumab: An Anti-Interleukin-6 Receptor Antibody , 2013, BioMed research international.

[135]  Kelly A. Jones,et al.  Immunodepletion plasma proteomics by tripleTOF 5600 and Orbitrap elite/LTQ-Orbitrap Velos/Q exactive mass spectrometers. , 2013, Journal of proteome research.

[136]  Maoshan Chen,et al.  iTRAQ-Based Proteomics Identification of Serum Biomarkers of Two Chronic Hepatitis B Subtypes Diagnosed by Traditional Chinese Medicine , 2016, BioMed research international.

[137]  Yuling Chen,et al.  Identification of Potential Serum Biomarkers for Rheumatoid Arthritis by High-Resolution Quantitative Proteomic Analysis , 2014, Inflammation.

[138]  Yin-kun Liu,et al.  Discovering potential serological biomarker for chronic Hepatitis B Virus-related hepatocellular carcinoma in Chinese population by MAL-associated serum glycoproteomics analysis , 2017, Scientific Reports.

[139]  N. Oreiro,et al.  Identification of a panel of novel serum osteoarthritis biomarkers. , 2011, Journal of proteome research.

[140]  W. Sui,et al.  Quantitative proteomic analysis of Down syndrome in the umbilical cord blood using iTRAQ. , 2015, Molecular medicine reports.

[141]  Qiang Gao,et al.  Oxidative stress induced carbonylation in human plasma. , 2011, Journal of proteomics.

[142]  J. Michel,et al.  ApoA-I/HDL-C levels are inversely associated with abdominal aortic aneurysm progression , 2015, Thrombosis and Haemostasis.

[143]  Development of Serum Glycoproteomic Profiling Technique; Simultaneous Identification of Glycosylation Sites and Site-Specific Quantification of Glycan Structure Changes* , 2010, Molecular & Cellular Proteomics.

[144]  J. Yates,et al.  Direct analysis of protein complexes using mass spectrometry , 1999, Nature Biotechnology.

[145]  L. Lang,et al.  iTRAQ-based proteomic profiling of human serum reveals down-regulation of platelet basic protein and apolipoprotein B100 in patients with hematotoxicity induced by chronic occupational benzene exposure. , 2012, Toxicology.

[146]  Jicheng Li,et al.  Screening and identification of five serum proteins as novel potential biomarkers for cured pulmonary tuberculosis , 2015, Scientific Reports.

[147]  S. Gygi,et al.  MS3 eliminates ratio distortion in isobaric labeling-based multiplexed quantitative proteomics , 2011, Nature Methods.

[148]  M. Loh,et al.  Reduced plasma APOA1 level is associated with gastric tumor growth in MKN45 mouse xenograft model. , 2010, Journal of proteomics.

[149]  Christoph H. Borchers,et al.  Proteomic Signatures in Plasma during Early Acute Renal Allograft Rejection* , 2010, Molecular & Cellular Proteomics.

[150]  Q. Shan,et al.  Quantitative proteomic analysis by iTRAQ for identification of candidate biomarkers in plasma from acute respiratory distress syndrome patients. , 2013, Biochemical and biophysical research communications.

[151]  Chuan Wang,et al.  The Potential Role of ORM2 in the Development of Colorectal Cancer , 2012, PloS one.

[152]  A. Skubitz,et al.  Quantitative proteomic analysis by iTRAQ® for the identification of candidate biomarkers in ovarian cancer serum , 2010, Proteome Science.

[153]  H. Gendelman,et al.  Changes in the plasma proteome follows chronic opiate administration in simian immunodeficiency virus infected rhesus macaques. , 2012, Drug and alcohol dependence.

[154]  B. Roschitzki,et al.  Discovery of serum proteomic biomarkers for prediction of response to infliximab (a monoclonal anti-TNF antibody) treatment in rheumatoid arthritis: an exploratory analysis. , 2012, Journal of proteomics.

[155]  Richard D. Smith,et al.  IgY14 and SuperMix immunoaffinity separations coupled with liquid chromatography-mass spectrometry for human plasma proteomics biomarker discovery. , 2012, Methods.

[156]  Juncong Yang,et al.  MRM‐based multiplexed quantitation of 67 putative cardiovascular disease biomarkers in human plasma , 2012, Proteomics.

[157]  A. Galande,et al.  Serum biomarkers reveal long-term cardiac injury in isoproterenol-treated African green monkeys. , 2013, Journal of proteome research.

[158]  Aditi Chatterjee,et al.  Plasma Proteome Database as a resource for proteomics research: 2014 update , 2013, Nucleic Acids Res..

[159]  Jason Liao,et al.  Proteomic profiling of human plasma by iTRAQ reveals down-regulation of ITI-HC3 and VDBP by cigarette smoking. , 2011, Journal of proteome research.

[160]  Investigation of ovarian cancer associated sialylation changes in N-linked glycopeptides by quantitative proteomics , 2012, Clinical Proteomics.

[161]  R. Cole,et al.  Global Screening of Human Cord Blood Proteomes for Biomarkers of Toxic Exposure and Effect , 2008, Environmental health perspectives.

[162]  M. Loh,et al.  ITIH3 is a potential biomarker for early detection of gastric cancer. , 2010, Journal of proteome research.

[163]  Xiaoyan Zhang,et al.  Altered protein expression in serum from endometrial hyperplasia and carcinoma patients , 2011, Journal of hematology & oncology.

[164]  A. V. D. Van Der Zee,et al.  Influence of clotting time on the protein composition of serum samples based on LC-MS data. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[165]  Ishtiaq Rehman,et al.  iTRAQ underestimation in simple and complex mixtures: "the good, the bad and the ugly". , 2009, Journal of proteome research.

[166]  F. Regnier,et al.  Differential carbonylation of proteins as a function of in vivo oxidative stress. , 2011, Journal of proteome research.

[167]  David R. Goodlett,et al.  Quantitative Mass Spectrometry Analysis Using PAcIFIC for the Identification of Plasma Diagnostic Biomarkers for Abdominal Aortic Aneurysm , 2011, PloS one.

[168]  Xinyu Zhao,et al.  Complementary serum proteomic analysis of autoimmune hepatitis in mice and patients , 2013, Journal of Translational Medicine.

[169]  B. McManus,et al.  Molecular signatures of end-stage heart failure. , 2011, Journal of cardiac failure.

[170]  T. Kondo,et al.  Quantitative proteomic analysis identified paraoxonase 1 as a novel serum biomarker for microvascular invasion in hepatocellular carcinoma. , 2013, Journal of Proteome Research.

[171]  Phillip C. Wright,et al.  An insight into iTRAQ: where do we stand now? , 2012, Analytical and Bioanalytical Chemistry.

[172]  Qing Yang,et al.  Identification of GlcNAcylated alpha-1-antichymotrypsin as an early biomarker in human non-small-cell lung cancer by quantitative proteomic analysis with two lectins , 2016, British Journal of Cancer.

[173]  Lanping Xu,et al.  Ceruloplasmin Is a Potential Biomarker for aGvHD following Allogeneic Hematopoietic Stem Cell Transplantation , 2013, PloS one.

[174]  Jicheng Li,et al.  Serum protein S100A9, SOD3, and MMP9 as new diagnostic biomarkers for pulmonary tuberculosis by iTRAQ‐coupled two‐dimensional LC‐MS/MS , 2015, Proteomics.

[175]  Jicheng Li,et al.  A Group of Novel Serum Diagnostic Biomarkers for Multidrug-Resistant Tuberculosis by iTRAQ-2D LC-MS/MS and Solexa Sequencing , 2016, International journal of biological sciences.

[176]  Diederick E Grobbee,et al.  Searching for early breast cancer biomarkers by serum protein profiling of pre-diagnostic serum; a nested case-control study , 2011, BMC Cancer.

[177]  K. Parker,et al.  Multiplexed Protein Quantitation in Saccharomyces cerevisiae Using Amine-reactive Isobaric Tagging Reagents*S , 2004, Molecular & Cellular Proteomics.

[178]  Michael J. Walker,et al.  A Label-free Selected Reaction Monitoring Workflow Identifies a Subset of Pregnancy Specific Glycoproteins as Potential Predictive Markers of Early-onset Pre-eclampsia* , 2013, Molecular & Cellular Proteomics.

[179]  S. Cross,et al.  iTRAQ Identification of Candidate Serum Biomarkers Associated with Metastatic Progression of Human Prostate Cancer , 2012, PloS one.

[180]  Hwee Tong Tan,et al.  Proteomics discovery of biomarkers for mitral regurgitation caused by mitral valve prolapse. , 2013, Journal of proteomics.

[181]  G. Siuzdak,et al.  Quantitative plasma proteomic profiling identifies the vitamin E binding protein afamin as a potential pathogenic factor in SIV induced CNS disease. , 2010, Journal of proteome research.

[182]  K. Lilley,et al.  Identification of protein biomarkers in human serum using iTRAQ and shotgun mass spectrometry. , 2013, Methods in molecular biology.

[183]  Matthias Mann,et al.  Plasma Proteome Profiling to Assess Human Health and Disease. , 2016, Cell systems.

[184]  A. Xu,et al.  Lower Fetuin-A, Retinol Binding Protein 4 and Several Metabolites after Gastric Bypass Compared to Sleeve Gastrectomy in Patients with Type 2 Diabetes , 2014, PloS one.

[185]  Quantification of Serum Proteins of Metastatic Oral Cancer Patients Using LC-MS/MS and iTRAQ Labeling. , 2008, The open proteomics journal.

[186]  Kunzheng Wang,et al.  Comparative study of serum proteomes in Legg-Calve-Perthes disease , 2015, BMC Musculoskeletal Disorders.

[187]  Arunangshu Das,et al.  Proteomic profiling of human plasma identifies apolipoprotein E as being associated with smoking and a marker for squamous metaplasia of the lung , 2015, Proteomics.

[188]  Proteomic profiling for the identification of serum diagnostic biomarkers for abdominal and thoracic aortic aneurysms , 2013, Proteome Science.

[189]  Johan Lindberg,et al.  A systems biology approach to understanding elevated serum alanine transaminase levels in a clinical trial with ximelagatran , 2009, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[190]  J. Kellum,et al.  Additions to the Human Plasma Proteome via a Tandem MARS Depletion iTRAQ-Based Workflow , 2013, International journal of proteomics.

[191]  J. van der Greef,et al.  The art and practice of systems biology in medicine: mapping patterns of relationships. , 2007, Journal of proteome research.

[192]  Establishment of a Strategy for the Discovery and Verification of Low-Abundance Biomarker Peptides in Plasma Using Two Types of Stable-Isotope Tags. , 2014, Mass spectrometry.

[193]  Ruedi Aebersold,et al.  Quantitative variability of 342 plasma proteins in a human twin population , 2015 .

[194]  H. Li,et al.  Screening differential expression of serum proteins in AFP-negative HBV-related hepatocellular carcinoma using iTRAQ -MALDI-MS/MS. , 2013, Neoplasma.

[195]  Hasmik Keshishian,et al.  Multiplexed, Quantitative Workflow for Sensitive Biomarker Discovery in Plasma Yields Novel Candidates for Early Myocardial Injury* , 2015, Molecular & Cellular Proteomics.

[196]  S. Sze,et al.  Data for iTRAQ profiling of micro-vesicular plasma specimens: In search of potential prognostic circulatory biomarkers for Lacunar infarction , 2015, Data in brief.

[197]  B. McManus,et al.  Proteomic biomarkers of recovered heart function , 2014, European journal of heart failure.

[198]  E. Gamelin,et al.  A Proteomic Approach for Plasma Biomarker Discovery with iTRAQ Labelling and OFFGEL Fractionation , 2009, Journal of biomedicine & biotechnology.

[199]  N. Anderson,et al.  A List of Candidate Cancer Biomarkers for Targeted Proteomics , 2006, Biomarker insights.

[200]  H. Isoniemi,et al.  Relative Quantification of Several Plasma Proteins during Liver Transplantation Surgery , 2011, Journal of biomedicine & biotechnology.

[201]  D. Gozal,et al.  Serum proteomic changes in adults with obstructive sleep apnoea , 2012, Journal of sleep research.

[202]  S. Sreevatsan,et al.  Biomarker Discovery in Subclinical Mycobacterial Infections of Cattle , 2009, PloS one.

[203]  Jicheng Li,et al.  Discovery and identification of serum potential biomarkers for pulmonary tuberculosis using iTRAQ‐coupled two‐dimensional LC‐MS/MS , 2014, Proteomics.

[204]  H. Friess,et al.  iTRAQ reveals candidate pancreatic cancer serum biomarkers: influence of obstructive jaundice on their performance , 2013, British Journal of Cancer.

[205]  M. Dunn,et al.  A comparison of the bovine uterine and plasma proteome using iTRAQ proteomics , 2012, Proteomics.

[206]  Hongtao Li,et al.  Discovery and verification of serum differential expression proteins for pulmonary tuberculosis. , 2015, Tuberculosis.

[207]  R. Buckanovich,et al.  Identification and confirmation of differentially expressed fucosylated glycoproteins in the serum of ovarian cancer patients using a lectin array and LC-MS/MS. , 2012, Journal of proteome research.

[208]  Eithne Costello,et al.  Analysis of serum proteins by LC-MS/MS. , 2010, Methods in molecular biology.

[209]  Chi Bun Ching,et al.  VKORC1 Pharmacogenetics and Pharmacoproteomics in Patients on Warfarin Anticoagulant Therapy: Transthyretin Precursor as a Potential Biomarker , 2010, PloS one.

[210]  S. Fisher,et al.  Evaluating the effects of preanalytical variables on the stability of the human plasma proteome. , 2015, Analytical biochemistry.

[211]  Kunzheng Wang,et al.  Serum Proteomic Analysis Based on iTRAQ in Miners Exposed to Soil Containing Rare Earth Elements , 2015, Biological Trace Element Research.

[212]  S. Walsh,et al.  The serum proteome of nonalcoholic fatty liver disease: A multimodal approach to discovery of biomarkers of nonalcoholic steatohepatitis , 2014, Journal of gastroenterology and hepatology.

[213]  Michael J. Walker,et al.  Protein Z: A putative novel biomarker for early detection of ovarian cancer , 2016, International journal of cancer.

[214]  Michelle A. Anderson,et al.  Quantitative Analysis of Single Amino Acid Variant Peptides Associated with Pancreatic Cancer in Serum by an Isobaric Labeling Quantitative Method , 2014, Journal of proteome research.

[215]  L. Boulet,et al.  Plasma proteomics can discriminate isolated early from dual responses in asthmatic individuals undergoing an allergen inhalation challenge , 2012, Proteomics. Clinical applications.

[216]  Mack T. Ruffin,et al.  Glycoprotein Biomarker Panel for Pancreatic Cancer Discovered by Quantitative Proteomics Analysis , 2014, Journal of proteome research.

[217]  D. Formanowicz,et al.  iTRAQ-based proteomic analysis of plasma reveals abnormalities in lipid metabolism proteins in chronic kidney disease-related atherosclerosis , 2016, Scientific Reports.

[218]  A. Secord,et al.  Autoantibody biomarkers identified by proteomics methods distinguish ovarian cancer from non-ovarian cancer with various CA-125 levels , 2013, Journal of Cancer Research and Clinical Oncology.

[219]  M. Kussmann,et al.  Proteomics of human plasma: A critical comparison of analytical workflows in terms of effort, throughput and outcome , 2013 .

[220]  R. Lewensohn,et al.  Evaluation of three principally different intact protein prefractionation methods for plasma biomarker discovery. , 2008, Journal of proteome research.

[221]  P. Hu,et al.  The role of von Willebrand factor as a biomarker of tumor development in hepatitis B virus-associated human hepatocellular carcinoma: a quantitative proteomic based study. , 2014, Journal of proteomics.

[222]  M. Harel,et al.  Proteomics of Microparticles with SILAC Quantification (PROMIS-Quan): A Novel Proteomic Method for Plasma Biomarker Quantification* , 2015, Molecular & Cellular Proteomics.